Nancy Tappenden

521 total citations
7 papers, 356 citations indexed

About

Nancy Tappenden is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Nancy Tappenden has authored 7 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Cancer Research and 2 papers in Genetics. Recurrent topics in Nancy Tappenden's work include Global Cancer Incidence and Screening (7 papers), Colorectal Cancer Screening and Detection (4 papers) and Breast Cancer Treatment Studies (3 papers). Nancy Tappenden is often cited by papers focused on Global Cancer Incidence and Screening (7 papers), Colorectal Cancer Screening and Detection (4 papers) and Breast Cancer Treatment Studies (3 papers). Nancy Tappenden collaborates with scholars based in United Kingdom, Netherlands and Australia. Nancy Tappenden's co-authors include Olive Kearins, Gill Lawrence, Matthew Wallis, P C Allgood, Stephen W. Duffy, E O'Sullivan, Irıs D. Nagtegaal, Nehmat Houssami, Jane Warwick and Fay Cafferty and has published in prestigious journals such as Cancer, American Journal of Epidemiology and British Journal of Cancer.

In The Last Decade

Nancy Tappenden

7 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Tappenden United Kingdom 6 252 124 62 52 50 7 356
E O'Sullivan United Kingdom 4 196 0.8× 86 0.7× 45 0.7× 49 0.9× 66 1.3× 6 322
B. Munárriz Spain 8 236 0.9× 129 1.0× 38 0.6× 48 0.9× 67 1.3× 19 364
Maria Rica Mirasol‐Lumague Philippines 8 223 0.9× 67 0.5× 35 0.6× 75 1.4× 48 1.0× 14 336
Nagi S. El-Saghir Lebanon 9 122 0.5× 83 0.7× 55 0.9× 23 0.4× 46 0.9× 21 277
Huub M. Kluck Netherlands 8 311 1.2× 148 1.2× 92 1.5× 21 0.4× 81 1.6× 8 387
Sabine Berendse United Kingdom 8 184 0.7× 46 0.4× 31 0.5× 20 0.4× 71 1.4× 10 292
Eugenio Vinés Chile 6 208 0.8× 96 0.8× 42 0.7× 35 0.7× 92 1.8× 11 348
Jia-Yuan Li China 7 284 1.1× 177 1.4× 69 1.1× 37 0.7× 56 1.1× 11 421
Zhong-Hua Tang China 7 277 1.1× 182 1.5× 76 1.2× 37 0.7× 57 1.1× 9 415
Bassim Al Bahrani Oman 12 207 0.8× 81 0.7× 37 0.6× 51 1.0× 90 1.8× 53 433

Countries citing papers authored by Nancy Tappenden

Since Specialization
Citations

This map shows the geographic impact of Nancy Tappenden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Tappenden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Tappenden more than expected).

Fields of papers citing papers by Nancy Tappenden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Tappenden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Tappenden. The network helps show where Nancy Tappenden may publish in the future.

Co-authorship network of co-authors of Nancy Tappenden

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Tappenden. A scholar is included among the top collaborators of Nancy Tappenden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Tappenden. Nancy Tappenden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Allgood, P C, S W Duffy, Olive Kearins, et al.. (2011). Explaining the difference in prognosis between screen-detected and symptomatic breast cancers. British Journal of Cancer. 104(11). 1680–1685. 62 indexed citations
2.
Nagtegaal, Irıs D., P C Allgood, Stephen W. Duffy, et al.. (2010). Prognosis and pathology of screen‐detected carcinomas. Cancer. 117(7). 1360–1368. 45 indexed citations
3.
Lawrence, Gill, et al.. (2009). Screening histories of invasive breast cancers diagnosed 1989–2006 in the West Midlands, UK: variation with time and impact on 10-year survival. Journal of Medical Screening. 16(4). 186–192. 25 indexed citations
4.
Duffy, Stephen W., Irıs D. Nagtegaal, Matthew Wallis, et al.. (2008). Correcting for Lead Time and Length Bias in Estimating the Effect of Screen Detection on Cancer Survival. American Journal of Epidemiology. 168(1). 98–104. 182 indexed citations
5.
Lawrence, Gill, Matthew Wallis, P C Allgood, et al.. (2008). Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias. Breast Cancer Research and Treatment. 116(1). 179–185. 36 indexed citations
6.
O’Sullivan, E., et al.. (2006). Pathology quality assurance: the use of control charts. Breast Cancer Research. 8(S1). 1 indexed citations
7.
Lawrence, Gill, et al.. (2005). The West Midlands breast cancer screening status algorithm – methodology and use as an audit tool. Journal of Medical Screening. 12(4). 179–184. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026